Cancers of the esophagus and stomach often require treatment with more than one type of chemotherapy agent. Researchers now know which medication is best if initial, or first-line, therapy fails.

Stomach or gastric cancer is not particularly common in this country, with just under 21,500 Americans diagnosed with it every year. Worldwide, though, it’s the second leading cause of cancer deaths. So finding new treatments are of international importance.